Search

1. Safety considerations for container labels and carton labeling design to minimize medication errors

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2022

Subject(s):

Drug Labeling -- legislation & jurisprudence
Medication Errors -- prevention & control
Patient Safety
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2023

Subject(s):

Direct-to-Consumer Advertising -- legislation & jurisprudence
Direct-to-Consumer Advertising -- standards
Disclosure
Drug Industry
Drug Labeling -- legislation & jurisprudence
Drug Labeling -- standards
Government Regulation
United States

3. Providing regulatory submissions in electronic and non-electronic format: promotional labeling and advertising materials for human prescription drugs

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2022

Subject(s):

Advertising -- legislation & jurisprudence
Advertising -- standards
Drug Approval
Drug Labeling -- legislation & jurisprudence
Drug Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

4. Cross labeling oncology drugs in combination regimens: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2022

Subject(s):

Antineoplastic Combined Chemotherapy Protocols
Drug Labeling -- legislation & jurisprudence
Government Regulation
United States
United States. Food and Drug Administration